Alto Neuroscience (ANRO) Institutional Ownership → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free ANRO Stock Alerts $12.24 +0.43 (+3.64%) (As of 01:19 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Alto Neuroscience (NYSE:ANRO)Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$57.78MNumber ofInstitutional Sellers(last 12 months)0 Get ANRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Alto Neuroscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANRO Institutional Buying and Selling by Quarter Ad The Freeport SocietyBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. Alto Neuroscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 RA Capital Management L.P.1,385,491$21.27M0.3%N/A5.154% 5/17/2024 Artal Group S.A.350,000$5.37M0.1%N/A1.302% 5/17/2024 Zimmer Partners LP75,000$1.15M0.0%N/A0.279% 5/16/2024 AWM Investment Company Inc.299,147$4.59M0.6%N/A1.113% 5/15/2024 Price T Rowe Associates Inc. MD637,604$9.79M0.0%N/A2.372% 5/10/2024 Vanguard Group Inc.536,332$8.23M0.0%N/A1.995% 5/2/2024 Jennison Associates LLC458,599$7.04M0.0%N/A1.706% 4/30/2024 University of Texas Texas AM Investment Managment Co.22,175$340K0.1%N/A0.082% (Data available from 1/1/2016 forward) ANRO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANRO shares? During the previous two years, the following institutional investors and hedge funds held shares of Alto Neuroscience shares: RA Capital Management L.P. ($21.27M), Price T Rowe Associates Inc. MD ($9.79M), Vanguard Group Inc. ($8.23M), Jennison Associates LLC ($7.04M), Artal Group S.A. ($5.37M), AWM Investment Company Inc. ($4.59M), and Zimmer Partners LP ($1.15M).Learn more on ANRO's institutional investors. Which institutional investors have been buying Alto Neuroscience stock? The following institutional investors have purchased Alto Neuroscience stock in the last 24 months: RA Capital Management L.P. ($1.39M), Price T Rowe Associates Inc. MD ($637.60K), Vanguard Group Inc. ($536.33K), Jennison Associates LLC ($458.60K), Artal Group S.A. ($350K), AWM Investment Company Inc. ($299.15K), and Zimmer Partners LP ($75K). How much institutional buying is happening at Alto Neuroscience? Institutional investors have bought a total of 3,764,348 shares in the last 24 months. This purchase volume represents approximately $57.78M in transactions. Related Companies: MannKind Institutional Ownership Calliditas Therapeutics AB (publ) Institutional Ownership Day One Biopharmaceuticals Institutional Ownership AbCellera Biologics Institutional Ownership Mirum Pharmaceuticals Institutional Ownership Prothena Institutional Ownership Collegium Pharmaceutical Institutional Ownership Enliven Therapeutics Institutional Ownership Cassava Sciences Institutional Ownership Arcturus Therapeutics Institutional Ownership This page (NYSE:ANRO) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.